Quick take: Today’s useful developments are not promises of frictionless progress. They are decisions that expose the conditions underneath access: evidence after a drug approval, bargaining power after a strike, responsibility across a marketplace, and the real cost of a parcel crossing a border.
A new myeloma treatment is approved—but the decisive evidence is still being gathered
On 13 August, the US Food and Drug Administration granted accelerated approval to iberdomide, sold as Zenbexus, with daratumumab and dexamethasone for adults whose multiple myeloma has returned or resisted treatment. Iberdomide is the first approved member of a class called CELMoDs, which recruits the cereblon protein to help remove proteins that cancer cells need. The promising part is a new mechanism reaching patients after at least one prior treatment line, rather than remaining a laboratory prospect. But accelerated approval is conditional: the decision rests on improved minimal residual disease, while the ongoing trial must still confirm that patients live longer without progression. The FDA also requires restricted distribution and a boxed warning for embryo-fetal toxicity; Bristol Myers Squibb says a 28-day cycle will list at $29,500. For a patient or family, “approved” therefore does not mean proven superior for every outcome or readily affordable. A realistic action is to ask the treating team which endpoint supports the recommendation, what alternatives exist, and how access and reproductive-risk safeguards will work in practice. FDA decision, 13 August; Reuters report, 13 August.
Tesla ends Sweden’s longest strike by removing the strikers, not resolving the dispute
IF Metall said on 13 August that it will end industrial action against Tesla on 19 August after the company bought out all its remaining striking members. The nearly three-year conflict began when service mechanics sought a collective agreement; none was signed. There is a limited benefit for the individuals who accepted compensation, and the outcome makes the actual balance of power unusually visible. Its danger is broader: a company with enough capital may neutralise collective action employee by employee while leaving the underlying terms, representation and workplace voice unsettled. Tesla did not immediately answer Reuters’ request for comment; the union’s account of the buyouts is therefore the principal public explanation. For workers elsewhere—and for customers who associate electric vehicles with social as well as environmental progress—the episode shows that a low-carbon product does not automatically bring a durable labour settlement. One practical action is to look beyond product specifications when choosing an employer, contractor or vehicle: ask whether local service workers have collective representation, documented grievance routes and terms that survive management changes. IndustriALL/IF Metall statement, 13 August; Reuters report, 13 August.
A UK ruling narrows when an online marketplace owns a seller’s infringement
London’s High Court rejected Shein’s attempt to hold Temu liable for merchants’ use of Shein product photographs, Reuters reported on 13 August. Judge Kelyn Bacon found that Temu had not authorised the alleged infringement and said that, even if infringement were established, the platform could rely on the hosting defence because it lacked specific knowledge. Temu also succeeded on a counterclaim concerning listings removed under an injunction involving images Shein did not own. The promise is legal clarity: marketplaces are not automatically treated as the publisher of every seller upload, which can preserve room for small merchants. The danger is a responsibility gap. Servers outside the UK, third-party uploads and knowledge thresholds can leave creators facing expensive, cross-border enforcement while platforms profit from scale. For shoppers, duplicated photos are also a warning that an image may not reliably identify who made or will supply the item. Before buying, reverse-search a product photo, inspect the named seller and return address, and preserve the listing and receipt. Creators should keep dated originals and make takedown notices precise enough to establish ownership and identify the exact material. Reuters report, 13 August.
A US court lets the president close the low-value import exemption early
On 13 August, the US Court of International Trade upheld the president’s use of emergency powers to suspend the “de minimis” tariff exemption for low-value imports from China, Mexico and Canada. The three-judge panel distinguished removing an existing trade privilege from imposing new tariffs—the broader power the Supreme Court rejected in February. Congress has already legislated to end the exemption, but only from July 2027; this judgment permits the earlier executive suspension to stand. Closing the channel may improve customs scrutiny and reduce an advantage enjoyed by sellers structured around thousands of direct parcels. The limitation is institutional as well as economic: the ruling expands what a president may change through emergency authority, while small importers and consumers absorb abrupt compliance costs. A retailer built around the old rule may reprice, delay or withdraw products, and a cheap order may acquire duties or handling fees after checkout. Before ordering across a border, check the seller’s country, the stated landed price, the carrier’s fee policy and the return route; compare that total with a domestic or repairable alternative. Court opinion, 13 August; Reuters report, 13 August.
If this morning review helps you see the machinery behind the headlines, subscribe to receive the next edition.